RE:FEB 8 TWEET FROM OFFICISL SZLS TWITTER...Yes, I saw that article as well. Official posting(on their website) for release of Aristotle as much as stagezero can convey their plans as of late. But the investment community would rather have something straight from the company. My guess it is just a foreshadowing of the real deal. To be honest, stagezero is already tied up with covid testing. I see a gradual conversion to cancer testing and no big spike in sales in that regards. A tempered growth would be well suited for the rise in market cap to avoid the hype, pump and dump meme style attitude lately. Remember that stagezero is cash cow. Think Berkshire. They (Berkshire) have loads of cash and would rather hold cash in this bubbling stock market. Tripp has an awesome outlook and foresaw the telehealth angle years ago and now has adjusted to the cash angle. Brilliant decisions. GLTA.
MoreUpThanDown wrote: So SZLS posted this from their Twitter account in Feb. Not sure it's been posted here yet, don't recall seeing it... Anyhow, it relates to an article noting the same, but why would SZLS post this if they were not going to do it? That is what some might be thinking and believing... while others may have a more positive viewpoint. Guess it's always up to you to decide how you will interpret these things. Note the status update and the acknowledgement regarding Shareholders looking for an update. IMHO. Do your own DD ............................StageZero Life Sciences @StageZeroLS 8 Feb With #CancerTesting #Telehealth Platform on Track for Q1 Launch, StageZero Shareholders Await #Covid19Testing Related Revenue Results https://bit.ly/39XCxdT $SZLS